TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,098
|
1,956
|
1,751 |
Financial expenses |
16
|
8
|
0 |
Earnings before taxes |
699
|
-534
|
-697 |
EBITDA |
627
|
-577
|
-710 |
Total assets |
4,109
|
3,404
|
2,829 |
Current assets |
3,888
|
3,120
|
2,530 |
Current liabilities |
3,009
|
3,005
|
2,303 |
Equity capital |
1,100
|
399
|
526 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
16
![]() |
16
|
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.8%
|
11.7%
|
18.6% |
Turnover per employee |
194
|
122
|
125 |
Profit as a percentage of turnover |
22.6%
|
-27.3%
|
-39.8% |
Return on assets (ROA) |
17.4%
|
-15.5%
|
-24.6% |
Current ratio |
129.2%
|
103.8%
|
109.9% |
Return on equity (ROE) |
63.5%
|
-133.8%
|
-132.5% |
Change turnover |
1,136
|
347
|
76 |
Change turnover % |
58%
|
22%
|
5% |
Chg. No. of employees |
0
|
2
|
1 |
Chg. No. of employees % |
0%
|
14%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.